SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor

All categories
Name
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
Accession Number
DBCAT005510
Description

Not Available

Drugs
DrugDrug Description
RemdesivirA nucleoside analog used to treat RNA virus infections including COVID-19.
Drugs & Drug Targets
DrugTargetType
RemdesivirReplicase polyprotein 1abtarget
RemdesivirRNA-directed RNA polymerase Ltarget
RemdesivirCytochrome P450 2C8enzyme
RemdesivirCytochrome P450 2D6enzyme
RemdesivirCytochrome P450 3A4enzyme
RemdesivirSolute carrier organic anion transporter family member 1B1transporter
RemdesivirP-glycoprotein 1transporter
RemdesivirSolute carrier organic anion transporter family member 1B3transporter
RemdesivirBile salt export pumptransporter
RemdesivirMultidrug resistance-associated protein 4transporter
RemdesivirSodium/bile acid cotransportertransporter
RemdesivirLiver carboxylesterase 1enzyme
RemdesivirLysosomal protective proteinenzyme
RemdesivirReplicase polyprotein 1abtarget
RemdesivirReplicase polyprotein 1abtarget
RemdesivirMultidrug and toxin extrusion protein 1transporter